Medexus Pharmaceuticals Inc. provided revenue guidance for the second fiscal quarter ended September 30, 2022. For the quarter, the company expects revenue to be between $27.0 million and $27.5 million. This will represent the strongest fiscal quarter in Medexus's history, and an increase of at least 51% compared to $17.9 million in fiscal second quarter 2022 and an increase of at least 17% compared to $23.0 million in fiscal first quarter 2023.

Primary drivers for the most recent quarter's revenue.